Cargando…
Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
To investigate the possible mechanism of Qingyihuaji formula (QYHJ) for reversing gemcitabine (GEM) resistant human pancreatic cancer. Cell proliferation, apoptosis, migration and invasion were detected in CFPAC-1 cells. Xenograft mice established with CFPAC-1 through subcutaneous on 33 immunodefici...
Autores principales: | Chen, Peng, Wang, Meiying, Wang, Cuiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579980/ https://www.ncbi.nlm.nih.gov/pubmed/31147453 http://dx.doi.org/10.1042/BSR20190610 |
Ejemplares similares
-
High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway
por: HUA, YONG-QIANG, et al.
Publicado: (2014) -
Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells
por: Gao, Song, et al.
Publicado: (2016) -
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013) -
The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022)